Low intensity directed ultrasound (LODUS) mediated blood brain barrier disruption

• US 7,896,821 B1
• Filed: 11/12/2004
• Issued: 03/01/2011
• Est. Priority Date: 11/14/2003
• Status: Active Grant

• Current Assignee: Albert S. Kyle
• Original Assignee: Perfusion Technology, LLC
• Inventors: Magnin, Paul A., Herken, Ulrich, Kyle, Albert S.
• Primary Examiner(s): Chen; Tse
• Assistant Examiner(s): CHAO, ELMER M
• Application Number:
  US10/987,398
• Time in Patent Office: 2,300 Days
• Field of Search: 600/407, 600/437, 600/439, 604/22, 604/28, 604/511, 604/500, 604/501, 604/522, 604/518, 604/898, 601 2- 4
• US Class Current: 601/2
• CPC Class Codes: A61H 2201/0207 heated
• CPC Class Codes: A61H 2201/0221 Mechanism for heating or cooling
• CPC Class Codes: A61H 2201/1607 Holding means therefor
• CPC Class Codes: A61H 2201/165 Wearable interfaces
• CPC Class Codes: A61H 2201/5002 Means for controlling a set of similar massage devices acting in sequence at different locations on a patient
• CPC Class Codes: A61H 2201/5035 Several programs selectable
• CPC Class Codes: A61H 2205/02 Head
• CPC Class Codes: A61H 23/0245 with ultrasonic transducers, e.g. piezoelectric
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

A method and device selectively and reversibly disrupts the blood-brain barrier (BBB) in a selected volume of the brain without the need for exogenous agents. The method and device employ low intensity directed ultrasound (LODUS) that is safe, reduces the danger of cavitation and thermal tissue damage, and is able to expose small or large regions of the brain to achieve a desired therapeutic or prophylactic effect.

Claims

1. A method of delivering a therapeutic or prophylactic agent through the blood-brain barrier of an animal body, comprising introducing said agent into the blood stream in the absence of exogenous bubble-forming agents and, in conjunction therewith, transiently disrupting a region of the blood-brain barrier by applying thereto low intensity directed unfocused ultrasound (LODUS) having a mechanical index of less than 1 and a frequency of less than 1.0 megahertz (MHz) to facilitate passage of said therapeutic or prophylactic agent from the bloodstream and through the blood-brain barrier.

2. The method of claim 1 in which said ultrasound is characterized by a mechanical index of approximately from 0.1 to 0.6.

3. The method of claim 1 in which said ultrasound is characterized by a frequency of approximately 300 kHz.

4. A method of delivering a therapeutic or prophylactic agent through the blood-brain barrier of an animal body, comprising introducing said agent into the blood stream in the absence of exogenous bubble-forming agents and, in conjunction therewith, transiently disrupting a region of the blood-brain barrier by sonically creating a stable oscillation of endogenous microbubbles therein by applying thereto low intensity directed unfocused ultrasound (LODUS) having a mechanical index of less than 1 and a frequency of approximately 300 kHz to thereby enable delivery of said therapeutic or prophylactic agent from the bloodstream through said region.